Average Co-Inventor Count = 3.27
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aventis Behring Gmbh (7 from 57 patents)
2. Rhone-poulenc Industries (2 from 521 patents)
3. Rhone-poulenc S.a. (2 from 142 patents)
4. Novozymes Biopharma UK Limited (2 from 4 patents)
5. Rhone-poulenc Agrochimie (1 from 221 patents)
6. Novozymes Biopharma Dk A/s (1 from 16 patents)
15 patents:
1. 7833521 - Methods of treating using hormone-albumin fusion proteins
2. 7435410 - Methods of treatment with interferson and albumin fusion protein
3. 7410779 - Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
4. 7094577 - Insulin and albumin fusion protein
5. 7081354 - Interleukin and albumin fusion protein
6. 7056701 - Hormone and albumin fusion protein
7. 7041478 - G-CSF and albumin fusion protein
8. 6989365 - Methods of treatment with erythropoietin and albumin fusion protein
9. 6987006 - Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof
10. 6972322 - Interferon and albumin fusion protein
11. 5021350 - Process for inclusion of mycorrhizae and actinorhizae in a matrix
12. 4886664 - Low-water-activity inocula for biological control
13. 4755468 - Inocula of low water activity with improved resistance to temperature
14. 4599312 - Method of producing endomycorrhizian fungi with arbuscules and vesicles
15. 4434231 - Means for embedding microorganisms in a polymer matrix